This activity is intended for clinicians, researchers, fellows, residents, medical students, and allied health professionals with an interest in current clinical trends and approaches for the diagnosis and treatment of movement disorders.
1. Evaluate the pharmacological and non-pharmacological management options available for Parkinson’s disease and other movement disorders
2. Discuss the diagnostic approaches and tools available for Parkinson’s disease and other movement disorders
3. Describe the pathogenesis and neurobiology of Parkinson’s disease and other movement disorders
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 26.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit of individual sessions is not available.
All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. All relevant financial relationships have been mitigated in advance of this program.
View faculty disclosure information.
Content Validity Statement
All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.
EACCME Accreditation Statement
The International Congress Of Parkinson's Disease And Movement Disorders, Madrid, Spain, 55/09/2022-18/09/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 25 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.